Plain-English translation of NCT07656454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medicine called CDR132L that is being developed to help people with heart failure. Researchers want to compare two different ways of giving this medication: as an injection under the skin versus directly into a vein. By studying how much of the medication enters your bloodstream with each method, they can figure out which way works best for patients.
Heart failure is a serious condition, and doctors need better treatment options. Before this medication can be tested in patients with heart failure, researchers need to understand how the body absorbs and processes it when given in different ways. This information will help them choose the safest and most effective delivery method.
You likely qualify if…
You likely don't qualify if…
You will receive two injections of the medication during the study—one given under your skin and one given directly into a vein. These injections may be given in different orders depending on which study group you're assigned to, and the study team will also test two different doses. Throughout the study, researchers will take blood samples to measure how much medication reaches your bloodstream and monitor you for any side effects.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Germany